Rockefeller Capital Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-8,019
| Closed | -$2.28M | – | 1519 |
|
|
2023
Q2 | $2.28M | Sell |
8,019
-2,337
| -23% | -$664K | 0.01% | 803 |
|
|
2023
Q1 | $2.88M | Buy |
10,356
+3,891
| +60% | +$1.08M | 0.01% | 707 |
|
|
2022
Q4 | $1.79M | Buy |
6,465
+300
| +5% | +$83K | 0.01% | 790 |
|
|
2022
Q3 | $1.65M | Sell |
6,165
-192
| -3% | -$51.2K | 0.01% | 826 |
|
|
2022
Q2 | $1.3M | Sell |
6,357
-177
| -3% | -$36.1K | 0.01% | 910 |
|
|
2022
Q1 | $1.38M | Buy |
6,534
+333
| +5% | +$70.1K | 0.01% | 949 |
|
|
2021
Q4 | $1.49M | Sell |
6,201
-7,219
| -54% | -$1.73M | 0.01% | 907 |
|
|
2021
Q3 | $3.8M | Sell |
13,420
-2,151
| -14% | -$609K | 0.02% | 556 |
|
|
2021
Q2 | $5.39M | Sell |
15,571
-3,340
| -18% | -$1.16M | 0.03% | 433 |
|
|
2021
Q1 | $5.29M | Buy |
18,911
+3,942
| +26% | +$1.1M | 0.04% | 352 |
|
|
2020
Q4 | $3.66M | Sell |
14,969
-7,974
| -35% | -$1.95M | 0.03% | 379 |
|
|
2020
Q3 | $6.51M | Sell |
22,943
-1,022
| -4% | -$290K | 0.06% | 235 |
|
|
2020
Q2 | $6.41M | Sell |
23,965
-539
| -2% | -$144K | 0.07% | 220 |
|
|
2020
Q1 | $7.75M | Buy |
24,504
+8,139
| +50% | +$2.57M | 0.1% | 182 |
|
|
2019
Q4 | $4.86M | Sell |
16,365
-4,192
| -20% | -$1.24M | 0.06% | 225 |
|
|
2019
Q3 | $4.79M | Sell |
20,557
-229,540
| -92% | -$53.4M | 0.06% | 201 |
|
|
2019
Q2 | $58.5M | Sell |
250,097
-4,154
| -2% | -$971K | 0.82% | 34 |
|
|
2019
Q1 | $60.1M | Sell |
254,251
-72,747
| -22% | -$17.2M | 0.86% | 29 |
|
|
2018
Q4 | $98.4M | Buy |
326,998
+5,376
| +2% | +$1.62M | 1.72% | 17 |
|
|
2018
Q3 | $114M | Buy |
321,622
+37,049
| +13% | +$13.1M | 1.72% | 17 |
|
|
2018
Q2 | $82.6M | Sell |
284,573
-3,291
| -1% | -$955K | 1.34% | 27 |
|
|
2018
Q1 | $78.8M | Buy |
+287,864
| New | +$78.8M | 1.3% | 25 |
|